What is Excelsior Sciences?
Excelsior Sciences is at the forefront of transforming small molecule innovation by developing chemistry that is both machine-performable and AI-usable. The company's proprietary 'smart bloccs' are automated, synthesis-ready, and AI-readable building blocks that constitute a modular chemical language. This innovative approach is designed to accelerate both the discovery and manufacturing processes within the pharmaceutical and chemical industries. With a demonstrated track record in automated synthesis and AI integration, Excelsior Sciences is committed to delivering safer, more effective, and sustainable chemical solutions.
How much funding has Excelsior Sciences raised?
Excelsior Sciences has raised a total of $70M across 1 funding round:
Series A
$70M
Series A (2025): $70M with participation from Deerfield, Khosla Ventures, and Sofinnova Partners
Key Investors in Excelsior Sciences
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy, supporting companies across the healthcare ecosystem with flexible funding models and driving innovation using AI, data, and market research.
Khosla Ventures
Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies, focusing on a broad range of areas including consumer, enterprise, AI, fintech, semiconductors, health, agriculture/food, sustainable energy, and robotics.
Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability, acting as a hands-on company builder across the entire value chain of life sciences investments.
What's next for Excelsior Sciences?
The recent major strategic investment signals a new phase of growth and scaling for Excelsior Sciences. This capital is expected to fuel further development of its AI-readable building block technology and expand its reach in both discovery and manufacturing. The company's focus on creating a modular chemical language positions it to significantly impact the efficiency and sustainability of chemical innovation, potentially leading to faster development cycles for novel therapeutics and materials.
See full Excelsior Sciences company page
